Investigational New Drug Application
An investigational new drug application is a required request for authorization from the Food and Drug Administration to administer an investigational medicine or biological product to humans. (NIH)
An investigational new drug application is a required request for authorization from the Food and Drug Administration to administer an investigational medicine or biological product to humans. (NIH)
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.
